Cancer drug prices set to drop as Kenya seals deal with Pfizer

Kenya has reached an agreement with Pfizer to significantly reduce the cost of cancer drugs, benefiting patients across the nation. President William Ruto disclosed that the deal, under Pfizer’s Accord for a Healthier World programme, will slash the price of treatments for various cancers, including breast, stomach, colon, lung, prostate, oesophageal, leukaemia, lymphoma, and multiple myeloma.

The cost of treatment could drop from as high as Ksh1 million to less than Ksh50,000 per cycle, making the Ksh800,000 cancer treatment package under the Social Health Authority fully adequate for patients. This agreement also expedites access to newer cancer medicines, eliminating the existing 10-year waiting period. Ruto highlighted the partnership's potential to boost local pharmaceutical manufacturing in Africa through technology and medicine access.

Brief written by urgent.news from KBC's own syndicated text. Machine-written — may contain errors; check the original before relying on it.